Literature DB >> 17327931

Henoch-Schönlein purpura: recurrence and chronicity.

Camila S Alfredo1, Nicole A Nunes, Cláudio A Len, Cássia M P Barbosa, Maria Teresa R A Terreri, Maria Odete E Hilário.   

Abstract

OBJECTIVES: To describe a group of patients treated at our service for Henoch-Schönlein purpura, with emphasis on recurrent and chronic cases, and to compare clinical and demographic characteristics of patients with monocyclic and recurrent disease.
METHODS: Data on 67 patients who had been treated since disease onset were analyzed. Twelve patients were excluded because they failed to return for follow-up consultations after less than 3 months, leaving a total of 55 children in the study sample. Recurrence was defined as the presence of a fresh episode after a period of at least 3 months without symptoms, and cases were defined as chronic when cutaneous, abdominal and renal manifestations persisted for a period of 12 months or more.
RESULTS: Recurrence was observed in 8/55 patients (14.4%) and four cases were chronic (7.2%). In 29/55 patients (52.7%), infection was identified as the trigger factor. A monocyclic clinical course was observed in 43 patients (26 of whom were girls, with a mean age of 5.4 years). Gastrointestinal and renal involvement was observed in 55.8 and 20.9% of patients, respectively. Among the 12 patients with recurrent or chronic Henoch-Schönlein purpura, three had arthritis, four exhibited signs and symptoms of abdominal involvement and seven of kidney disease: microscopic hematuria in five, macroscopic hematuria in one and hematuria with proteinuria in one other. Late onset was the only variable related to recurrence (p < 0.05).
CONCLUSIONS: As is observed in medical literature, monocyclic cases are more common among children with early onset disease. Patients with Henoch-Schönlein purpura should be followed over the long term, since recurrent and chronic cases account for more than 20% of the total.

Entities:  

Mesh:

Year:  2007        PMID: 17327931     DOI: 10.2223/JPED.1595

Source DB:  PubMed          Journal:  J Pediatr (Rio J)        ISSN: 0021-7557            Impact factor:   2.197


  11 in total

1.  Outcome of Henoch-Schönlein purpura 8 years after treatment with a placebo or prednisone at disease onset.

Authors:  Outi Jauhola; Jaana Ronkainen; Olli Koskimies; Marja Ala-Houhala; Pekka Arikoski; Tuula Hölttä; Timo Jahnukainen; Jukka Rajantie; Timo Örmälä; Matti Nuutinen
Journal:  Pediatr Nephrol       Date:  2012-02-05       Impact factor: 3.714

2.  Risk Factors Associated with Renal Involvement in Childhood Henoch-Schönlein Purpura: A Meta-Analysis.

Authors:  Han Chan; Yan-Ling Tang; Xiao-Hang Lv; Gao-Fu Zhang; Mo Wang; Hai-Ping Yang; Qiu Li
Journal:  PLoS One       Date:  2016-11-30       Impact factor: 3.240

3.  Incidence and risk factors for recurrent Henoch-Schönlein purpura in children from a 16-year nationwide database.

Authors:  Wei-Te Lei; Po-Li Tsai; Szu-Hung Chu; Yu-Hsuan Kao; Chien-Yu Lin; Li-Ching Fang; Shyh-Dar Shyur; Yu-Wen Lin; Shu-I Wu
Journal:  Pediatr Rheumatol Online J       Date:  2018-04-16       Impact factor: 3.054

4.  Risk factors for renal involvement and severe kidney disease in 2731 Chinese children with Henoch-Schönlein purpura: A retrospective study.

Authors:  Ke Wang; Xiaomei Sun; Yang Cao; Liang Dai; Feiyang Sun; Ping Yu; Liqun Dong
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

5.  Childhood cutaneous vasculitis: a comprehensive appraisal.

Authors:  Aparna Palit; Arun C Inamadar
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

Review 6.  Pathophysiological Relationship between Infections and Systemic Vasculitis.

Authors:  Carolina Muñoz-Grajales; Juan C Pineda
Journal:  Autoimmune Dis       Date:  2015-07-07

7.  Relapses in patients with Henoch-Schönlein purpura: Analysis of 417 patients from a single center.

Authors:  Vanesa Calvo-Río; José Luis Hernández; Francisco Ortiz-Sanjuán; Javier Loricera; Natalia Palmou-Fontana; Maria C González-Vela; Domingo González-Lamuño; Marcos A González-López; Susana Armesto; Ricardo Blanco; Miguel A González-Gay
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

8.  Henoch-Schönlein purpura with c-ANCA antibody in an adult.

Authors:  Pedro de Freitas Silva Torraca; Bruna Corrêa de Castro; Günter Hans
Journal:  An Bras Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.896

Review 9.  Vasculitis and infections: contribution to the issue of autoimmunity reviews devoted to "autoimmunity and infection".

Authors:  Cees G M Kallenberg; Henko Tadema
Journal:  Autoimmun Rev       Date:  2008-08-12       Impact factor: 9.754

10.  Onset age is a risk factor for refractory pediatric IgA vasculitis: a retrospective cohort study.

Authors:  Chun-Hua Liao; Melody Tsai; Yao-Hsu Yang; Bor-Luen Chiang; Li-Chieh Wang
Journal:  Pediatr Rheumatol Online J       Date:  2020-11-10       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.